Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study
Cancer Medicine · 2023
DOI: 10.1002/cam4.6658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Shuixiang Tao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shaoxing People's Hospital (Zhejiang University Shaoxing Hospital), Shaoxing, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Medical and Health Science and Technology Project.
Abstract (Originalsprache)
Background
Currently there is no specific molecular biomarker for the diagnosis and treatment of renal cell carcinoma (RCC). Here we performed a gender‐specific two‐sample Mendelian randomization analysis to systematically assess the effects of circulating cytokines on RCC.
Methods
We have employed cis‐quantitative trait loci as instrumental variables for the protein levels and expression of circulating cytokines. We estimated the causal effects of circulating cytokines on RCC risk in males and females with several Mendelian randomization methods.
Results
We observed a significant causal effect of Eotaxin on the increased risk of RCC in males (Odds ratio [OR] = 2.546, 95% confidence interval [CI] = 1.617–4.010, p value = 5.496 × 10–5), but not in females (OR = 1.352, 95% CI = 0.766–2.388, p value = 0.298). Besides, we also identified several cytokines as potentially associated with RCC in males including RANTES, MCP3, PDGFbb, TRAIL, and several other cytokines as potentially associated with RCC in females including sICAM and SCGFb.
Conclusion
Our study highlighted that a higher level of circulating Eotaxin is causally associated with an increased risk of RCC in males but not in females. Further studies are needed to elucidate the exact mechanism and its potential application in the prognosis and treatment of RCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shaoxing People's Hospital (Zhejiang University Shaoxing Hospital), Shaoxing, Zhejiang, China.
- Department of Urology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Urology, The People's Hospital of Pujiang County, Jinhua, Zhejiang, China.
ORCID-Profile: Hong Chen
Förderung
- Zhejiang Medical and Health Science and Technology Project
Zitieren
APA
Tao, S., Lin, Y., Huang, S., Lin, S., Jin, K., & Chen, H. (2023). Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study. Cancer Medicine. https://doi.org/10.1002/cam4.6658
Vancouver
Tao S, Lin Y, Huang S, Lin S, Jin K, Chen H. Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study. Cancer Medicine. 2023. doi:10.1002/cam4.6658
BibTeX
@article{Tao2023,
author = {Tao, Shuixiang and Lin, Yiwei and Huang, Shengqiang and Lin, Shen and Jin, Ke and Chen, Hong},
title = {Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6658}
}
EUVIMED